Pitching Endpoints News Cancer Reporters: Vertical Press Strategy
Endpoints News is a must-win outlet for biotech and pharma PR. Its Cancer coverage rewards speed, specificity, and clinical substance — not brand storytelling.
This guide gives you a repeatable playbook for reaching Endpoints News Cancer reporters with pitches that survive the inbox.
Editorial Scope: What Endpoints News Covers in Cancer#
Endpoints focuses on the business and science of drug development: trial readouts, FDA decisions, deals, pricing, and pipeline strategy.
Cancer coverage skews toward oncology data that moves markets — ASCO/AACR abstracts, Phase 2/3 results, approvals, and competitive positioning.
💡 Vertical Pro Tip: Lead with the clinical or regulatory news hook, not the company milestone. If your pitch reads like a press release, it dies.
Identifying Active Writers on the Endpoints News Cancer Reporters List#
The Cancer beat is lean — often one or a few active writers at a time. Precision beats spray-and-pray.
Start with the Endpoints News Cancer reporters list in your media database and verify recent bylines. Representative writer Shehla Shakoor is a useful anchor for this beat.
| Factor | Recommended Strategy | What Gets Ignored |
|---|---|---|
| Beat fit | Match pitch to writer's recent oncology bylines | Generic "healthcare reporter" blasts |
| Timing | Pitch 24–48h before data drop or embargo lift | Pitches sent after the story runs |
| Hook | Trial data, regulatory action, deal terms | Company anniversary or rebrand news |
| Length | 3–5 sentences, data-first | Multi-paragraph backgrounders |
| Exclusivity | Offer a first look or on-record exec | Mass-distributed releases |
Angles & Data Points That Resonate With Endpoints News Cancer Journalists#
Endpoints News Cancer journalists want numbers, not adjectives. Give them endpoint data, hazard ratios, patient numbers, and comparator context.
Strong angles: first-in-class mechanisms, trial misses with clear implications, pricing debates, and M&A that reshapes the competitive landscape.
Weak angles: "promising early data" without figures, patient-story-only pitches, and vague partnership announcements.
💡 Vertical Pro Tip: Include the one-line "why now" and the competitive stakes in your subject line. Endpoints readers are investors and BD teams.
Outreach Protocols & Accessing Endpoints News Cancer Journalists Contacts#
Verify Endpoints News Cancer journalists contacts through the outlet's staff page and recent byline links before sending. Cross-check against your database for stale emails.
Email is the default channel. Keep it short, put the news in the first line, and offer a named spokesperson with direct availability.
Respect embargoes precisely — Endpoints moves fast, and early breaks damage the relationship. Follow up once, no more.
Fast-Action Pitch Checklist for Cancer#
- Confirm the writer actively covers oncology (check last 30 days of bylines)
- Lead with the data point or regulatory event in sentence one
- Include comparator context and market implication
- Offer an exclusive or first-look where possible
- State embargo terms clearly and honor them
- Provide a responsive, named spokesperson
- Log the interaction in your Endpoints News Cancer reporters list for future targeting
Pitch the science and the stakes, and the Endpoints News Cancer reporters covering this beat will take the call.